SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing intense volatility and a massive sell-off after Marvell canceled purchase orders linked to Celestial AI, citing a confidentiality breach by management. The community is sharply divided between investors demanding management accountability for the delayed disclosure of this news and those betting on a recovery based on the company's underlying optical technology.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group Inc. is experiencing intense selling pressure and record-low valuations, leaving investors deeply divided between those viewing the current price as a long-term bargain due to PIF and Uber backing and those fearing further dilution, a potential reverse split, or even bankruptcy. The community is heavily focused on the disconnect between the company's high-performance vehicle technology and its ongoing struggle to sustain share price momentum amid persistent capital burn.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is capturing significant community attention following the successful completion of historic point-to-point air taxi demonstration flights in New York City. Investors are closely monitoring the company's transition from prototype testing to real-world infrastructure integration as they progress through critical FAA certification phases.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science SA is trending due to a breakthrough in molecular farming involving the successful expression of bovine myoglobin in pea seeds, fueling investor excitement and high-volume trading activity. While bullish community members point to the potential for a massive short squeeze given the stock's low float, skeptics are actively debating the company's financials, dilution history, and the sustainability of the price surge.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is trending as investors react to the company's first revenue growth in 19 quarters and a strategic shift toward an 'Everything Home' marketplace. Community discussions are heavily divided, with some traders highlighting the operational turnaround and bullish technical setups, while skeptics remain focused on the company's past struggles and ongoing cash burn.

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

Orca is seeing significant volatility and community interest, driven by its role as a leading decentralized exchange on Solana and speculation regarding DAO-led buyback programs. Traders are actively debating its potential for a short squeeze and price appreciation, while monitoring its performance against broader market movements and platform integrations.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

High-Trend International Group is experiencing significant momentum and extreme volatility, with the community actively debating whether the move is a sustainable squeeze or a high-risk pump and dump. Traders are closely monitoring key technical levels and volume spikes, with many citing the stock's low float as the primary catalyst for its rapid, multi-day price fluctuations.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently driving significant community engagement following a massive earnings beat and upward guidance, with many investors debating whether the stock is a legitimate AI infrastructure play or if it has reached a parabolic, overextended peak. Discussion is heavily focused on the stock's rapid momentum and the contrasting views of bulls citing strong data center growth versus bears pointing to extreme technical indicators like RSI and the likelihood of a sharp correction.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is currently in focus following positive Phase 3 clinical trial results for its acne treatment in China, which has sparked optimism regarding its licensing strategy and potential U.S. development pathways. Investors are closely monitoring its MASH pipeline and combination therapy efforts, viewing the company as a significantly undervalued acquisition target relative to the billions of dollars in TAM across its therapeutic indications.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is facing significant volatility following its latest financial results, where the company provided conservative revenue guidance for the coming year despite strong performance from its antifungal drug REZZAYO and DefenCath. The community is actively debating the company's valuation, questioning the leadership's communication, and analyzing the impact of upcoming legislative and regulatory catalysts on the stock's future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Agriculture Investment Group currently owns a 65.1% stake in Moolec.</li><li>This followed a prior deal between Moolec’s unit, Bioceres, and AIGC.</li><li>MLEC stock has gained around 145% since the company implemented a reverse stock split in a one-for-fifteen ratio.</li></ul>Shares of Moolec Science SA (MLEC) drew strong retail interest Monday, rising over 35% and heading for a third straight gain, days after Agriculture Investment Group Corp. became its largest shareholder.According to an SEC filing dated April 2, Agriculture Investment Group Corp. (AIGC) became the controlling shareholder of Moolec Science, owning 65.1% of its shares after converting preference shares into ordinary shares.This followed a prior agreement between Bioceres Group and AIGC, and the completion of a business combination that made Bioceres a subsidiary of Moolec.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/MLEC">MLEC</a> on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes. Message volumes on the platform have increased by 50% over the past seven days.One user suggested the stock could rise due to growing demand for high-yield crop technology, driven by fertilizer shortages tied to the Middle East conflict.<stembedurl>https://stocktwits.com/Dang_Son/message/648113461</stembedurl>Another user sees key resistance levels at $13, $18, and $20. The stock is currently trading just above $9.<stembedurl>https://stocktwits.com/MoeTheTrader/message/649474095</stembedurl><h2 class="st-heading-2">Stock Sees Massive Gains Since Reverse Split</h2>On January 30, Moolec confirmed that the Nasdaq Stock Market Hearings Panel approved its request for continued listing after the company regained compliance with the minimum bid price requirements following a 1-for-15 reverse share split, which took effect on Jan. 5, 2026. The stock has surged more than 145% since the reverse split became effective.On February 13, the stock posted one of its biggest intraday gains of the year after the company reported strong results from the crushing phase of its U.S. GLASO safflower platform, confirming gamma-linolenic acid (GLA) levels of around 45%.Moolec cultivated about 1,100 acres of engineered safflower across the United States during the 2025 season. Average yields were around 2,200 pounds per acre, up from around 1,400 pounds in 2024, exceeding the company’s internal expectations.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/jamie-dimon-warns-of-high-inflation-and-interest-rates-if-us-israel-iran-war-continues/cZJ4ZSRRIYd">Jamie Dimon Warns Of High Inflation And Interest Rates If US-Israel-Iran War Continue</a>sFor updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

MLEC Stock Extends Its Relentless Rally, Sees 35% Boost Today After Change In Shareholding

According to an SEC filing dated April 2, Agriculture Investment Group became the controlling shareholder of Moolec Science.

Equity

Looking Into Moolec Science SA's Recent Short Interest

<ul class="summary-bullets"><li>Moolec cultivated about 1,100 acres of engineered safflower across the United States during the 2025 season.</li><li>Average yields were around 2,200 pounds per acre, exceeding the company’s expectations.</li><li>Moolec confirmed that the Nasdaq Stock Market Hearings Panel approved its request for continued listing on January 30.</li></ul>Shares of Moolec Science S.A. (MLEC) soared more than 130% on Friday after the company announced strong results from the crushing phase of its U.S. GLASO safflower platform, confirming gamma-linolenic acid (GLA) concentrations of around 45%.The milestone follows the successful completion of the company’s 2025 safflower campaign and validates its plant-engineered molecular farming technology for commercial-scale agricultural and industrial production, Moolec said.<h2 class="st-heading-2">Moolec’s Crushing Results Validate Scalability</h2>After harvest, the engineered safflower was processed through standard U.S. crushing facilities with results confirming that the GLASO platform can perform reliably at scale.Moolec cultivated about 1,100 acres of engineered safflower across the United States during the 2025 season. Average yields were around 2,200 pounds per acre, up from around 1,400 pounds in 2024, exceeding the company’s internal expectations.“Achieving approximately 45% GLA concentration at commercial scale confirms that our technology is not only scientifically differentiated, but operationally executable within existing U.S. agricultural and processing infrastructure. Our focus now is to build on this foundation through disciplined growth and the conversion of this operational advantage into sustainable, recurring revenue,” said Alejandro Antalich, CEO at Moolec Science.On January 30, Moolec confirmed that the Nasdaq Stock Market Hearings Panel approved its request for continued listing after the company regained compliance with the minimum bid price requirements following a one-for-15 reverse share split, which took effect earlier in the month.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, accompanied by ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/MLEC_jpg_62c7e429b6.webp" alt="MLEC.jpg">One user expects <a href="https://stocktwits.com/symbol/MLEC">MLEC shares</a> to climb to $20. It is currently trading at $11.4.<stembedurl>https://stocktwits.com/widar/message/644938608</stembedurl>Year-to-date, the stock has gained 241%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cnvs-stock-rallies-on-indicue-acquisition/cZR5xVUR4tc">CNVS Stock Surged 20% Today, Breaching 100-DMA For First Time Since August – Here’s What Triggered The Rally</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did This Nano-Cap Food Stock More Than Double In Value Today?

The company announced positive crushing results from its U.S. GLASO safflower platform, confirming GLA concentrations of about 45%.

Moolec Science (MLEC) Stock Explodes 90% After GLA Update

Moolec Science Inc shares are surging on Friday after the company reported commercial-scale data from its U.S.read more...

Earnings

Fed / Macro data

Headlines / Geopolitics

Other (drop a comment)

What will be the main driver of the market this week?

Stocktwits

Stocktwits Polls

Traders are targeting the extremely low ~500k share float for a potential parabolic breakout fueled by short interest.

Bullish investors are speculating on aggressive price moves, with many eyeing targets between $12 and $20 for the next session.

The stock is trending across social feeds due to increased volume and aggressive buying patterns reminiscent of previous volatile runners.

Some market participants are dismissing the hype as an organized pump and dump, pointing to high volatility and lack of fundamentals.

Current Price	$8.09
Prev Close	$7.27
Open	$7.17
Dividend Yield	0.00%
50-Day Moving Average	$9.57
Beta	0.07
Avg. Volume	57,325.83
PE Ratio	-0.25

52-Week High	$157.05
52-Week Low	$3.08
Market Capitalization	$5.28M
EPS (Annual)	-$258.69
Price to Book	0.77
Revenue Per Employee	$3.24M

MLEC
Moolec Science SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MLEC News

MLECMoolec Science SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MLEC News

MLEC
Moolec Science SA